
Captor Therapeutics S.A.
Research and experimental development in natural sciences and engineering
Overview
Captor Therapeutics is a biotech company that utilizes Targeted Protein Degradation (TPD) technology to discover and develop therapies for diseases with unmet medical needs, such as cancer and autoimmune disorders. The company operates from Basel, Switzerland, and Wrocław, Poland, and employs advanced techniques like CRISPR/Cas9 for genome editing and its Optigrade™ platform for drug candidate discovery. Their integrated expertise in protein engineering, structural biology, and molecular modeling enables them to optimize lead compounds effectively.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 26 days early. All were audited by a statutory auditor.
- 202525/06/2026
- 202402/07/2025
- 202302/07/2024
- 202229/06/2023
- 202114/07/2022
- 202016/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 53.50
- High
- PLN 53.50
- Low
- PLN 51.30
- Volume
- 720
- Avg. vol.
- 4.45K
- Market cap
- PLN 330.38M
- P/E ratio
- –
- EPS
- -PLN 6.97
- Shares outstanding
- 6.35M
- 52-week
- PLN 49.00 – 56.00
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLCPTRT00014
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 441.38k | USD -3.49m | USD -3.08m |
| Q1 2026 | USD 88.60k | USD -3.04m | USD -3.07m |
| Q4 2025 | USD 11.05k | USD -2.58m | USD -2.52m |
| Q3 2025 | USD 504.77k | USD -2.97m | USD -2.88m |
Results for Q3 2026:Nov 19, 2026
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Biological testing
- Chemical testing
- Drug development
- Drug candidate discovery
Websites
- captortherapeutics.plCaptor TherapeuticsNginx
- captortherapeutics.comCaptor TherapeuticsNginx
Job offers
The company has its own careers page: captortherapeutics.pl/kariera.
Authorized Representatives
Manner of representation
If the management board is a one-person management board, the company is represented by one member of the management board. If the management board is a multi-member management board, the company is represented by two members of the management board acting jointly.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-01-01.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 31, 2018 | Commercial Companies Code notice |
Public aid
24 public aid cases recorded, with a total value of $66,481,965.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 29, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Wrocławski Park Technologiczny S.A. | |
| Jul 17, 2023 | Aid for research and development projects: industrial research | –– | Prezes Agencji Badań Medycznych | |
| Jul 17, 2023 | Aid for research and development projects: experimental development | –– | Prezes Agencji Badań Medycznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-01-01 | A first-in-class mcl-1 degrader to promote apoptosis in therapy-resistant liquid and solid tumours | $2.7M$2,651,801 | 1.0.11 - Horizon Europe |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| JJP Biologics sp. z o.o. | $4,998,735.31 | jjpbiologics.com | ||
| Lipid Systems sp. z o.o. | $4,497,777.98 | lipidsystems.pl | ||
| Biotechna S.A. | $2,472,888.07 | bsbiotechna.com | ||
| Molecure S.A. | $1,889,300.60 | molecure.com | ||
| Neuca Clinical Trials Investments sp. z o.o. | $1,803,742.35 | neuca.pl | ||
| Scope Fluidics S.A. | $1,264,188.85 | scopefluidics.com | ||
| Pikralida sp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Śląski Park Technologii Medycznych Kardio-Med Silesia sp. z o.o. | $969,037.30 | kmptm.pl | ||
| Vasa Therapeutics sp. z o.o. | $363,111.30 | vasatherapeutics.com | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-19 | Share capital increase (635,339.70 PLN → 636,233.10 PLN) | |
| 2026-06-25 | Share capital increase (552,870.90 PLN → 635,339.70 PLN) | |
| 2025-04-29 | Share capital increase (549,557.10 PLN → 552,870.90 PLN) | |
| 2024-12-30 | Share capital increase (467,310.40 PLN → 549,557.10 PLN) | |
| 2024-12-12 | Share capital increase (466,284.60 PLN → 467,310.40 PLN) |
FAQ
Last updated: 2026-10-19
